Mindstrong is a healthcare innovation company transforming brain health through pioneering work in measurement science and new models of care delivery. Mindstrong’s health platform seeks to connect patients and providers with continuous, objective measures of cognition and mood giving patients agency in their care and providers confidence that they will be alerted to early signs of mental health deterioration.
Our Values : Science That Makes a Difference.
Board of Directors
Mindstrong's Board of Directors bring deep experience working at the intersection of academia and industry.
Rick Klausner, MD
Co-Founder and Executive Chairman, Mindstrong Health
Stephen Klasko, MD MBA
President and CEO, Thomas Jefferson University and Jefferson Health
Jim Tanabaum, MD
CEO and Founder, Foresite Capital
Hemant Taneja, M.Eng.
Managing Director, General Catalyst
Senior Principal, Optum Ventures
Tom Insel, MD
Co-Founder and President, Mindstrong Health
Paul Dagum, MD PHD
Founder and Chief Executive Officer, Mindstrong Health
Scientific Advisory Board
Mindstrong's Scientific Advisory Board provides leading scientific oversight and guidance.
Ian Gotlib, PhD
Professor and Chair, Psychology,
Sophia Vinogradov, MD
Professor and Head, Department of Psychiatry,
University of Minnesota
Philip D. Harvey, PhD
Leonard M. Miller Professor of Psychiatry
University of Miami
Amit Etkin, MD, PhD
Associate Professor of Psychiatry and Behavioral Science,
Michael Frumkin, MS
Director, Google Accelerated Science;
Walter Greenleaf, PhD
Stanford Virtual Human Interaction Lab
Ethical-Legal-Social Implications (ELSI) Board
Mindstrong's ELSI Board ensures that digital biomarkers for the diagnosis and treatment of mental health conditions earns and maintains public trust.
President & CEO, Mental Health America
President, One Mind
Nev Jones, PhD
Director of Research, Felton Institute
Nicole Martinez, PhD, JD
Postdoctoral Fellow, Stanford Bioethics
Sharon Terry, MA
President & CEO, Genetic Alliance
Katherine Switz, MBA
Founder & Executive Director, The Stability Network
Executive Director, Living Assistance Fund
Mindstrong’s investors have launched some of the most transformative biotechnology and healthcare companies in neuropsychiatry and neurodegeneration.
Mindstrong has developed and patented a biomarker panel that measures brain function from interaction patterns captured passively and continuously from human-computer interfaces found in ubiquitous mobile technology.